Morgan Stanley Has Lowered Expectations for Mettler-Toledo International (NYSE:MTD) Stock Price

Mettler-Toledo International (NYSE:MTD) had its price objective cut by Morgan Stanley from $1,550.00 to $1,475.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the medical instruments supplier’s stock. Morgan Stanley’s target price would indicate a potential upside of 4.07% from the company’s current price.

A number of other equities analysts also recently commented on MTD. Barclays cut their price objective on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a report on Monday, December 15th. Stifel Nicolaus upped their target price on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. The Goldman Sachs Group began coverage on shares of Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price target on the stock. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th. Finally, Citigroup lifted their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Six analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,435.42.

Mettler-Toledo International Stock Up 2.6%

Shares of NYSE MTD traded up $36.47 during midday trading on Tuesday, hitting $1,417.35. The stock had a trading volume of 31,296 shares, compared to its average volume of 138,563. The company has a market capitalization of $28.96 billion, a PE ratio of 33.66, a P/E/G ratio of 4.09 and a beta of 1.42. Mettler-Toledo International has a 1 year low of $946.69 and a 1 year high of $1,525.17. The stock has a 50 day simple moving average of $1,420.24 and a 200-day simple moving average of $1,361.25.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 5th. The medical instruments supplier reported $13.36 EPS for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The company had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.10 billion. During the same quarter in the prior year, the company posted $12.41 earnings per share. Mettler-Toledo International’s revenue for the quarter was up 8.1% compared to the same quarter last year. Mettler-Toledo International has set its Q1 2026 guidance at 8.600-8.750 EPS and its FY 2026 guidance at 46.050-46.700 EPS. As a group, analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current fiscal year.

Insider Activity

In other Mettler-Toledo International news, CFO Shawn Vadala sold 1,000 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total value of $1,511,000.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,990,168. The trade was a 15.90% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Patrick Kaltenbach sold 2,000 shares of the business’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the transaction, the chief executive officer owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. The trade was a 35.27% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 10,316 shares of company stock worth $15,270,015 in the last quarter. 0.77% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Elyxium Wealth LLC acquired a new position in shares of Mettler-Toledo International during the 4th quarter worth about $29,000. Versant Capital Management Inc raised its stake in Mettler-Toledo International by 42.1% during the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 8 shares during the period. SJS Investment Consulting Inc. raised its stake in Mettler-Toledo International by 2,700.0% during the third quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after buying an additional 27 shares in the last quarter. Salomon & Ludwin LLC bought a new stake in Mettler-Toledo International in the 3rd quarter valued at about $43,000. Finally, Root Financial Partners LLC acquired a new position in shares of Mettler-Toledo International during the 3rd quarter valued at $42,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.